5-[(E)-2-(furan-2-yl)ethenyl]-1-methyl-N-(2-phenylethyl)-3-propylpyrazolo[4,5-d]pyrimidin-7-amine
C23H25N5O — CID 155552655
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(E)-2-(furan-2-yl)ethenyl]-1-methyl-N-(2-phenylethyl)-3-propylpyrazolo[4,5-d]pyrimidin-7-amine
5-[(E)-2-(furan-2-yl)ethenyl]-1-methyl-N-(2-phenylethyl)-3-propylpyrazolo[4,5-d]pyrimidin-7-amine (PubChem CID 155552655) has the molecular formula C23H25N5O and a molecular weight of 387.49 g/mol. Its IUPAC name is 5-[(E)-2-(furan-2-yl)ethenyl]-1-methyl-N-(2-phenylethyl)-3-propylpyrazolo[4,5-d]pyrimidin-7-amine.
Molecular Properties
| Compound Name | 5-[(E)-2-(furan-2-yl)ethenyl]-1-methyl-N-(2-phenylethyl)-3-propylpyrazolo[4,5-d]pyrimidin-7-amine |
|---|---|
| PubChem CID | 155552655 |
| Molecular Formula | C23H25N5O |
| Molecular Weight | 387.49 g/mol |
| Exact Mass | 387.21 |
| IUPAC Name | 5-[(E)-2-(furan-2-yl)ethenyl]-1-methyl-N-(2-phenylethyl)-3-propylpyrazolo[4,5-d]pyrimidin-7-amine |
| SMILES | CCCc1nn(C)c2c(NCCc3ccccc3)nc(/C=C/c3ccco3)nc12 |
| InChI | InChI=1S/C23H25N5O/c1-3-8-19-21-22(28(2)27-19)23(24-15-14-17-9-5-4-6-10-17)26-20(25-21)13-12-18-11-7-16-29-18/h4-7,9-13,16H,3,8,14-15H2,1-2H3,(H,24,25,26)/b13-12+ |
| InChIKey | LMNXIMVYUWKPLG-OUKQBFOZSA-N |
| XLogP | 4.73 |
| TPSA | 68.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 387.49 |
| LogP ≤ 5 | 4.73 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155552655 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.